Trials / Completed
CompletedNCT00397176
Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women
Ascending, Single Dose Study of the Safety, Tolerability, and Pharmacokinetics of DVS SR Administered Orally to Healthy Japanese Female Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Female
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Safety, tolerability, and pharmacokinetics (PK) of desvenlafaxine succinate sustained release (DVS SR) in healthy Japanese female subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | desvenlafaxine succinate sustained release (DVS SR) |
Timeline
- Start date
- 2006-11-01
- Completion
- 2007-02-01
- First posted
- 2006-11-08
- Last updated
- 2007-12-28
Source: ClinicalTrials.gov record NCT00397176. Inclusion in this directory is not an endorsement.